Showing results (331-340 of 408) with videos related to

Sort By:
Pageof 41
Antimicrobial Agents and Chemotherapy|February 20, 2014
Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapyAnthony M Casapao, Susan L Davis, Viktorija O Barr, et al.
Antimicrobial Resistance and Infection Control|April 22, 2017
Staphylococcus aureus infections following knee and hip prosthesis insertion proceduresJean Marie Arduino, Keith S Kaye, Shelby D Reed, et al.
The Pediatric Infectious Disease Journal|September 13, 2007
Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spreadJay R McDonald, Charlene M Carriker, Brian C Pien, et al.
Diagnostic Microbiology and Infectious Disease|July 19, 2011
Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapyVered Schechner, Tamar Gottesman, Orna Schwartz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2023
An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent InfectionsKrishna Rao, Qianzi Zhao, Justin Bell, et al.
Frontiers in Medicine|July 12, 2021
Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 VaccinationKhitam Muhsen, Mitchell J Schwaber, Jihad Bishara, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 12, 2020
Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational studyMerlin Moni, A Sangita Sudhir, T S Dipu, et al.
Clinical Microbiology Reviews|October 9, 2025
Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosaJuan P Horcajada, Ana C Gales, Burcu Isler, et al.
Pageof 41